文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

玉屏风散通过JAK2-STAT3信号通路促进树突状细胞成熟,改善肝细胞癌微环境的免疫抑制。

Yu-Ping-Feng-San improve the immunosuppression of microenvironment in hepatocellular carcinoma by promoting the maturation of DCs through the JAK2-STAT3 pathway.

作者信息

Yao Fei, Yuan Qin, Yan Yichao, Liang Guoqiang, Zhou Liang, Xu Heng, Gao Shaomei, Zou Ting, Zhang Lurong

机构信息

Central Laboratory, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215000, Jiangsu, China.

Clinical Pharmaceutical Laboratory of Traditional Chinese Medicine, Suzhou Academy of Wumen Chinese Medicine, Suzhou, 215000, Jiangsu, China.

出版信息

Sci Rep. 2024 Dec 28;14(1):31522. doi: 10.1038/s41598-024-83197-7.


DOI:10.1038/s41598-024-83197-7
PMID:39733089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11682348/
Abstract

Yu-Ping-Feng-San (YPF) is a famous classical Chinese medicine formula known for its ability to boost immunity. YPF has been applied to enhance the immune status of tumor patients in clinical practice. However, there is still a lack of research on its immune regulatory effects and mechanisms in the tumor microenvironment. This study was designed to investigate the effects and mechanism of YPF on improving the immune suppression state of hepatocellular carcinoma (HCC) microenvironment. In an orthotopic mouse model of HCC, YPF improved the immune microenvironment of HCC immunosuppression, enhanced the maturation of dendritic cells (DCs), promoted the release of IL-12, and decreased the presence of JAK2, p-JAK2, STAT3, and p-STAT3 proteins in both tumor tissue and paracancerous tissues. YPF also could promote the maturation and reduce the activation of JAK2, p-JAK2, STAT3, and p-STAT3 proteins of mouse bone marrow-derived DCs induced by culture medium or tumor supernatant in vitro. Transient transfection of siRNA-STAT3 with DCs resulted in an increase in its maturation and its secretion of IL-12. On the whole, these combined effects of YPF served to ameliorate the HCC immune suppression microenvironment, which conducive to immune cells play the role of immune surveillance and killing liver cancer cells. The mechanisms of these combined effects were, at least in part, related to its inhibition of the activated JAK2-STAT3 signaling pathway in DCs within the HCC microenvironment.

摘要

玉屏风散(YPF)是一种著名的经典中药方剂,以其增强免疫力的能力而闻名。YPF已在临床实践中用于提高肿瘤患者的免疫状态。然而,关于其在肿瘤微环境中的免疫调节作用和机制仍缺乏研究。本研究旨在探讨YPF改善肝细胞癌(HCC)微环境免疫抑制状态的作用及机制。在HCC原位小鼠模型中,YPF改善了HCC免疫抑制的免疫微环境,增强了树突状细胞(DCs)的成熟,促进了IL-12的释放,并降低了肿瘤组织和癌旁组织中JAK2、p-JAK2、STAT3和p-STAT3蛋白的表达。YPF还可以促进体外培养基或肿瘤上清液诱导的小鼠骨髓来源DCs的成熟,并降低JAK2、p-JAK2、STAT3和p-STAT3蛋白的激活。用DCs瞬时转染siRNA-STAT3导致其成熟及IL-12分泌增加。总体而言,YPF的这些联合作用有助于改善HCC免疫抑制微环境,有利于免疫细胞发挥免疫监视和杀伤肝癌细胞的作用。这些联合作用的机制至少部分与其抑制HCC微环境中DCs内激活的JAK2-STAT3信号通路有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/8ab3c896cc01/41598_2024_83197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/82dbd82fa9a0/41598_2024_83197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/1b970000c354/41598_2024_83197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/6da15327e558/41598_2024_83197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/d990737201ff/41598_2024_83197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/8ab3c896cc01/41598_2024_83197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/82dbd82fa9a0/41598_2024_83197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/1b970000c354/41598_2024_83197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/6da15327e558/41598_2024_83197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/d990737201ff/41598_2024_83197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/8ab3c896cc01/41598_2024_83197_Fig5_HTML.jpg

相似文献

[1]
Yu-Ping-Feng-San improve the immunosuppression of microenvironment in hepatocellular carcinoma by promoting the maturation of DCs through the JAK2-STAT3 pathway.

Sci Rep. 2024-12-28

[2]
The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC).

Curr Drug Deliv. 2012-7

[3]
Curcumin Inhibits the Growth of Hepatocellular Carcinoma the MARCH1-mediated Modulation of JAK2/STAT3 Signaling.

Recent Pat Anticancer Drug Discov. 2025

[4]
NUSAP1 Promotes Immunity and Apoptosis by the SHCBP1/JAK2/STAT3 Phosphorylation Pathway to Induce Dendritic Cell Generation in Hepatocellular Carcinoma.

J Immunother. 2025

[5]
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.

Mol Cancer. 2011-12-15

[6]
Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.

Pharmacol Res. 2020-8

[7]
Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor.

J Integr Med. 2024-11

[8]
Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.

Br J Pharmacol. 2013-10

[9]
Yu-Ping-Feng-San alleviates inflammation in atopic dermatitis mice by TLR4/MyD88/NF-κB pathway.

J Ethnopharmacol. 2024-7-15

[10]
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.

J Exp Clin Cancer Res. 2020-11-25

本文引用的文献

[1]
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology.

J Gastrointest Oncol. 2024-8-31

[2]
Anti-tumor effect and hepatotoxicity mechanisms of psoralen.

Front Pharmacol. 2024-8-5

[3]
Exploring the multi-targeting phytoestrogen potential of Calycosin for cancer treatment: A review.

Medicine (Baltimore). 2024-5-3

[4]
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.

Science. 2023-2-17

[5]
The mononuclear phagocyte system in hepatocellular carcinoma.

World J Gastroenterol. 2022-12-7

[6]
Evolving therapeutic landscape of advanced hepatocellular carcinoma.

Nat Rev Gastroenterol Hepatol. 2023-4

[7]
Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies.

Cancers (Basel). 2022-9-8

[8]
Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma.

Chin Med. 2022-7-30

[9]
The Effect of Calycosin-7-O-β-D-Glucoside and its Synergistic Augmentation of Cisplatin-induced Apoptosis in SK-OV-3 Cells.

Curr Pharm Des. 2022

[10]
Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis.

Mol Oncol. 2022-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索